These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6168228)

  • 21. [Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin].
    Fischer AM; Bros A; Rafowicz S; Josso F
    C R Seances Acad Sci D; 1979 Mar; 288(10):887-9. PubMed ID: 89015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin III progressive function: a biochemical analysis.
    Gomperts ED; Izadi P
    Am J Hematol; 1983 Aug; 15(1):23-33. PubMed ID: 6410910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
    Pletcher CH; Cunningham MT; Nelsestuen GL
    J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the strength of binding of antithrombin III, protamine and poly(L-lysine) to heparin samples of different anticoagulant activities.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1986 Aug; 883(1):69-76. PubMed ID: 3730427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC; Sheffield WP; Rachubinski RA; Blajchman MA
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma.
    Schmidt B; Mitchell L; Ofosu FA; Andrew M
    Thromb Haemost; 1989 Dec; 62(4):1074-7. PubMed ID: 2482548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
    J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of alpha 2-macroglobulin-thrombin and alpha 2-macroglobulin-plasmin complexes with isolated hepatocytes.
    Spolarics Z; Mandl J; Machovich R; Lambin P; Garzó T; Antoni F; Horváth I
    Biochim Biophys Acta; 1985 Jun; 845(3):389-95. PubMed ID: 2408676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 36. Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.
    Horner AA; Young E
    J Biol Chem; 1982 Aug; 257(15):8749-54. PubMed ID: 7096332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.
    Edens RE; Fromm JR; Fromm SJ; Linhardt RJ; Weiler JM
    Biochemistry; 1995 Feb; 34(8):2400-7. PubMed ID: 7873519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.